AstraZeneca Market Cap 2006-2019 | AZN

AstraZeneca market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AstraZeneca market cap as of March 27, 2020 is $111.46B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $111.457B $24.384B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $324.693B 14.19
Roche Holding AG (RHHBY) Switzerland $266.851B 0.00
Merck (MRK) United States $181.927B 13.82
Novartis AG (NVS) Switzerland $181.694B 15.13
Pfizer (PFE) United States $171.422B 10.48
Novo Nordisk (NVO) Denmark $134.337B 23.06
Eli Lilly (LLY) United States $128.348B 22.20
Bristol-Myers Squibb (BMY) United States $119.174B 11.30
AbbVie (ABBV) United States $107.310B 8.13
Sanofi (SNY) France $106.276B 12.63
GlaxoSmithKline (GSK) United Kingdom $90.928B 11.53
Bayer (BAYRY) Germany $52.428B 7.56
H Lundbeck (HLUYY) Denmark $5.813B 10.10
Innoviva (INVA) United States $1.126B 7.78